{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:32:33Z","timestamp":1776781953370,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"crossref","award":["16K11330"],"award-info":[{"award-number":["16K11330"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"crossref","award":["19K09959"],"award-info":[{"award-number":["19K09959"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10384-021-00871-3","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T09:02:40Z","timestamp":1631005360000},"page":"836-842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intraocular surgery under adalimumab therapy in patients with refractory uveitis: a single center study of 23 eyes"],"prefix":"10.1007","volume":"65","author":[{"given":"Keiko","family":"Kunimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinya","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kezuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"871_CR1","first-page":"1","volume-title":"Uveitis: fundamentals and clinical practice","author":"RB Nussenblatt","year":"2010","unstructured":"Nussenblatt RB. Elements of the immune system and concepts of intraocular inflammatory disease pathogenesis. In: Nussenblatt RB, Whitcup SM, editors. Uveitis: fundamentals and clinical practice. 4th ed. China: Mosby Elsevier; 2010. p. 1\u201336.","edition":"4"},{"key":"871_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10384-006-0383-4","volume":"51","author":"H Goto","year":"2007","unstructured":"Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41\u20135.","journal-title":"Jpn J Ophthalmol"},{"key":"871_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0002-9394(76)90434-7","volume":"82","author":"RE Smith","year":"1976","unstructured":"Smith RE, Godfrey WA, Kimura SJ. Complications of chronic cyclitis. Am J Ophthalmol. 1976;82:277\u201382.","journal-title":"Am J Ophthalmol"},{"key":"871_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S0161-6420(99)90155-0","volume":"106","author":"N Okhravi","year":"1999","unstructured":"Okhravi N, Lightman SL, Towler HMA. Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology. 1999;106:710\u201322.","journal-title":"Ophthalmology"},{"key":"871_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000027443","volume":"213","author":"J Merayo-Lloves","year":"1999","unstructured":"Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213:300\u20134.","journal-title":"Ophthalmologica"},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ajo.2014.06.018","volume":"158","author":"S Mehta","year":"2014","unstructured":"Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol. 2014;158:676-692.e7.","journal-title":"Am J Ophthalmol"},{"key":"871_CR7","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2147\/OPTH.S72383","volume":"26","author":"A Shimizu","year":"2014","unstructured":"Shimizu A, Maruyama K, Yokoyama Y, Tsuda S, Ryu M, Nakazawa T. Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol. 2014;26:2383\u20139.","journal-title":"Clin Ophthalmol"},{"key":"871_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3109\/09273948.2016.1165259","volume":"25","author":"R Bansal","year":"2017","unstructured":"Bansal R, Gupta A, Gupta V, Mulkutkar S, Dogra M, Katoch D, et al. Safety and outcome of microincision vitreous surgery in uveitis. Ocul Immunol Inflamm. 2017;25:775\u201384.","journal-title":"Ocul Immunol Inflamm"},{"key":"871_CR9","first-page":"393","volume":"122","author":"K Maruyama","year":"2018","unstructured":"Maruyama K, Hashida N, Koh S, Nakazawa T, Nishida K. Efficacy of vitreous surgery for prolonged cases of intraocular inflammatory disease. Nippon Ganka Gakkai Zasshi. 2018;122:393\u20139 (in Japanese).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"871_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4172\/2155-9570.S1-004","volume":"04","author":"S Suzuki","year":"2013","unstructured":"Suzuki S. Cataract surgery during anti-TNF-\u03b1 therapy (infliximab) for Beh\u00e7et\u2019s disease. J Clinic Exp Ophthalmol. 2013;04:328\u201333.","journal-title":"J Clinic Exp Ophthalmol"},{"key":"871_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12886-018-0813-3","volume":"18","author":"F Fan","year":"2018","unstructured":"Fan F, Jia Z, Li K, Zhao X, Ma Q. Cataract surgery combined with micro-incision vitrectomy in patients with Behcet\u2019s disease uveitis. BMC Ophthalmol. 2018;18:158.","journal-title":"BMC Ophthalmol"},{"key":"871_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","volume":"111","author":"CC Murphy","year":"2004","unstructured":"Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D. Tumor necrosis factor\u03b1 blockade with infliximab for refractory uveitis and scleritis. Ophthalmology. 2004;111:352\u20136.","journal-title":"Ophthalmology"},{"key":"871_CR13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","volume":"125","author":"EB Suhler","year":"2018","unstructured":"Suhler EB, Ad\u00e1n A, Br\u00e9zin AP, Fortin E, Goto H, Jaffe GJ, et al. Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III. Ophthalmology. 2018;125:1075\u201387.","journal-title":"Ophthalmology"},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/archophthalmol.2011.2698","volume":"130","author":"AA Okada","year":"2012","unstructured":"Okada AA, Goto H, Ohno S, Mochizuki M, Ocular Beh\u00e7et\u2019s Disease Research Group of Japan. Multicenter study of infliximab for refractory uveoretinitis in Beh\u00e7et disease. Arch Ophthalmol. 2012;130:592\u20138.","journal-title":"Arch Ophthalmol"},{"key":"871_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s10384-010-0824-y","volume":"54","author":"T Sakai","year":"2010","unstructured":"Sakai T, Kanetaka A, Noro T, Tsuneoka H. Intraocular surgery in patients receiving infliximab therapy for Beh\u00e7et disease. Jpn J Ophthalmol. 2010;54:360\u20131.","journal-title":"Jpn J Ophthalmol"},{"key":"871_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/jop.2009.0054","volume":"25","author":"E Noda","year":"2009","unstructured":"Noda E, Yamanishi S, Shiraishi A, Ohashi Y. Cataract surgery under infliximab therapy in a patient with Beh\u00e7et\u2019s disease. J Ocul Pharmacol Ther. 2009;25:467\u201370.","journal-title":"J Ocul Pharmacol Ther"},{"key":"871_CR17","doi-asserted-by":"crossref","unstructured":"Khalil HEDM, el Gendy HA, Raafat HA, Haroun HE, Gheita TA, Bakir HM. The effectiveness of pre- and postoperative infliximab in controlling Beh\u00e7et\u2019s disease posterior uveitis in patients undergoing vitrectomy: a preliminary study. J Ophthalmol. 2017:8168369. https:\/\/pubmed.ncbi.nlm.nih.gov\/28484648.","DOI":"10.1155\/2017\/8168369"},{"key":"871_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/09273948.2018.1491605","volume":"27","author":"H Goto","year":"2019","unstructured":"Goto H, Zako M, Namba K, Hashida N, Kaburaki T, Miyazaki M, et al. Adalimumab in active and inactive, non-infectious uveitis: global results from the VISUAL I and VISUAL II trials. Ocul Immunol Inflamm. 2019;27:40\u201350.","journal-title":"Ocul Immunol Inflamm"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00417-011-1844-0","volume":"250","author":"RJ Erckens","year":"2012","unstructured":"Erckens RJ, Mostard RLM, Wijnen PAHM, Schouten JS, Drent M. Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol. 2012;250:713\u201320.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"871_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/09273940802187466","volume":"16","author":"L Iannetti","year":"2008","unstructured":"Iannetti L, Accorinti M, Liverani M, Caggiano C, Abdulaziz R, Pivetti-Pezzi P. Optical coherence tomography for classification and clinical evaluation of macular edema in patients with uveitis. Ocul Immunol Inflamm. 2008;16:155\u201360.","journal-title":"Ocul Immunol Inflamm"},{"key":"871_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10067-018-4228-6","volume":"38","author":"C Fabiani","year":"2019","unstructured":"Fabiani C, Vitale A, Rigante D, Emmi G, Bitossi A, Lopalco G, et al. Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients. Clin Rheumatol. 2019;38:407\u201315.","journal-title":"Clin Rheumatol"},{"key":"871_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Atmaca LS, Becker MD, Brezin AP, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"871_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan C-C, Roberge F. Standardizatlon of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467\u201371.","journal-title":"Ophthalmology"},{"key":"871_CR24","unstructured":"Ministry of Health Labour and Welfare Designated Disease Study Group. Diagnostic criteria of Behcet\u2019s disease (revised edition, 2003). In: Health science study: research on Behcet\u2019s disease, final report for 2002. Tokyo: Ministry of Health, Labour and Welfare. 2003. p. 11\u201313."},{"key":"871_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647\u201352.","journal-title":"Am J Ophthalmol"},{"key":"871_CR26","unstructured":"Ministry of Health Labour and Welfare Designated Disease Study Group. Diagnostic criteria of sarcoidosis. J Jpn Sarcoidosis Soc. 1991;201:159\u201362 (in Japanese)."},{"key":"871_CR27","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103:1418\u201322.","journal-title":"Br J Ophthalmol"},{"key":"871_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10384-012-0158-z","volume":"56","author":"N Ohguro","year":"2012","unstructured":"Ohguro N, Sonoda K-H, Takeuchi M, Matsumura M, Mochizuki M. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432\u20135.","journal-title":"Jpn J Ophthalmol"},{"key":"871_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/B978-1-4377-0667-3.00028-X","volume-title":"Uveitis: fundamentals and clinical practice","author":"RB Nussenblatt","year":"2010","unstructured":"Nussenblatt RB. Sympathetic ophthalmia. In: Nussenblatt RB, Whitcup SM, editors. Uveitis: fundamentals and clinical practice. 4th ed. China: Mosby Elsevier; 2010. p. 289\u2013302.","edition":"4"},{"key":"871_CR30","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/sj.eye.6702927","volume":"22","author":"V Gupta","year":"2008","unstructured":"Gupta V, Gupta A, Dogra MR. Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India. Eye (Lond). 2008;22:1459\u201364.","journal-title":"Eye (Lond)"},{"key":"871_CR31","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.ophtha.2017.03.036","volume":"124","author":"S Yamane","year":"2017","unstructured":"Yamane S, Sato S, Maruyama-Inoue M, Kadonosono K. Flanged intrascleral intraocular lens fixation with double-needle technique. Ophthalmology. 2017;124:1136\u201342.","journal-title":"Ophthalmology"},{"key":"871_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns JE. Trabeculectomy: preliminary report of a new method. Am J Ophthalmol. 1968;66:673\u20139.","journal-title":"Am J Ophthalmol"},{"key":"871_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1600-0420.1996.tb00687.x","volume":"74","author":"OU Ciftci","year":"1996","unstructured":"Ciftci OU, Ozdemir O. Cataract extraction in Beh\u00e7et\u2019s disease. Acta Ophthalmol Scand. 1996;74:74\u20136.","journal-title":"Acta Ophthalmol Scand"},{"key":"871_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0161-6420(94)31310-8","volume":"101","author":"YA Akova","year":"1994","unstructured":"Akova YA, Foster CS. Cataract surgery in patients with sarcoidosis-associated uveitis. Ophthalmology. 1994;101:473\u20139.","journal-title":"Ophthalmology"},{"key":"871_CR35","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1002\/art.11301","volume":"48","author":"T Ellerin","year":"2003","unstructured":"Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor \u03b1 therapy. Arthritis Rheum. 2003;48:3013\u201322.","journal-title":"Arthritis Rheum"},{"key":"871_CR36","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1136\/ard.2005.037762","volume":"64","author":"D Wendling","year":"2005","unstructured":"Wendling D, Balblanc J-C, Brousse A, Lohse A, Lehuede G, Garbuio P, et al. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Ann Rheum Dis. 2005;64:1378\u20139.","journal-title":"Ann Rheum Dis"},{"key":"871_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5144\/0256-4947.2014.328","volume":"34","author":"A Alfawaz","year":"2014","unstructured":"Alfawaz A, Alrashidi S, Kalantan H, Al-Mezaine H, Abu AM. Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease. Ann Saudi Med. 2014;34:328\u201333.","journal-title":"Ann Saudi Med"},{"key":"871_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ophtha.2013.09.023","volume":"121","author":"MH Levin","year":"2014","unstructured":"Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, et al. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 2014;121:588\u201395.","journal-title":"Ophthalmology"},{"key":"871_CR39","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.10302","volume":"46","author":"EW St. Clair","year":"2002","unstructured":"St. Clair EW, Wagner CL, Fasanmade AA, Wang B, Schaible T, Kavanaugh A, et al. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002;46:1451\u20139.","journal-title":"Arthritis Rheum"},{"key":"871_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/bcp.12509","volume":"79","author":"D Ternant","year":"2015","unstructured":"Ternant D, Ducourau E, Fuzibet P, Vignault C, Watier H, Lequerr\u00e9 T, et al. Pharmacokinetics and concentration\u2013effect relationship of adalimumab in rheumatoid arthritis. Br J Clin Pharmacol. 2015;79:286\u201397.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-021-00871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-021-00871-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-021-00871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T15:03:00Z","timestamp":1635087780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-021-00871-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1007\/s10384-021-00871-3","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. Kunimi, Financial Support (AbbVie, Eisai, Santen); Y. Usui, Financial Support (AbbVie, Eisai, Santen); K. Tsubota, None; T. Kezuka, None; H. Goto, Advisory board (AbbVie).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}